Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Withholding Antibiotics on Immune Responses in Bangladeshi Infants with Diarrhea
NCT07615842Phase 1Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azithromycin in diarrhea, cryptosporidiosis, rotavirus infection and 1 more (2 arms), sponsored by University of Virginia. Primary endpoint: T follicular helper activation at 1 year. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
diarrheacryptosporidiosisrotavirus infectionadenovirus infection
Beyond the preview
Go deeper on NCT07615842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07615842.